In May of 2018 Kite Pharma, a Gilead Company, announced the opening of a new Neo Antigen Facility in Gaithersburg, MD. Less than one year later in April of 2019, the company, announced that it was building a new biomanufacturing facility on a 20-acre site in Frederick, MD. Since then, Kite has been diligently working to build a world-class leadership team at both sites to achieve an important mission.
Those leaders are now onboard and are out sharing their important mission by engaging the regional community to recruit and hire the talent they need to fill more than 360 job openings across Maryland..
This November, in one of its first regional community events, Kite sponsored a BioBuzz ‘Meet and Greet’ networking event to get their message out to the local industry. A few dozen of Kite’s employees, including Chris McDonald, VP of Manufacturing and Frederick Site Head, and Wayne Hardy, Senior Director of Manufacturing and Site Head at Kite’s Neo Antigen Facility, shared the powerful, patient-focused “why” behind Kite’s mission.
“Kite is pleased and happy to be part of this community. We’re here to make a difference. We’re on a mission to cure cancer,” stated Hardy.
“There are a lot of people out there who are suffering… there is probably not a single person in this room untouched by cancer. Think about 10 years from now. You could be telling your kids or grandkids ‘I was part of the team focused on the cure.’ That’s why we’re here in this room right now,” he added.
Click here to read more via BioBuzz